ORIGINAL RESEARCH
Accepted on 17 Feb 2025
Inhaled Nitric Oxide as an Independent Intervention to Lower the Risk of Bronchopulmonary Dysplasia in Preterm Infants (<33 Weeks) with Pulmonary Hypertension within the Initial 3 Days of Life
doi 10.3389/fped.2025.1525329